Clinical Trial Update: A Study to Assess the Analgesic Efficacy and Safety of ASP8062 in Subjects With Fibromyalgia [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the analgesic efficacy and safety of ASP8062 in adults with fibromyalgia has completed, and results have been posted. The sponsor is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibromyalgia

Drugs mentioned

• ASP8062

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Fibromyalgia | Phase 2 | Status: COMPLETED | Results posted: 2019-03-28